These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116 [TBL] [Abstract][Full Text] [Related]
3. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA; Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433 [TBL] [Abstract][Full Text] [Related]
4. Update on immunizations in adults. Vaughn JA; Miller RA Am Fam Physician; 2011 Nov; 84(9):1015-20. PubMed ID: 22046942 [TBL] [Abstract][Full Text] [Related]
5. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
6. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(25):468-70. PubMed ID: 22739778 [TBL] [Abstract][Full Text] [Related]
7. Report from the CDC. Vaccines in women. Schmidt JV; Kroger AT; Roy SL J Womens Health (Larchmt); 2004 Apr; 13(3):249-57. PubMed ID: 15130253 [TBL] [Abstract][Full Text] [Related]
8. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(1):13-5. PubMed ID: 21228763 [TBL] [Abstract][Full Text] [Related]
9. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):374-5. PubMed ID: 19373199 [TBL] [Abstract][Full Text] [Related]
11. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services. Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252 [TBL] [Abstract][Full Text] [Related]
12. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
13. FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):203-4. PubMed ID: 12653460 [TBL] [Abstract][Full Text] [Related]
14. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(37):1279-80. PubMed ID: 21937974 [TBL] [Abstract][Full Text] [Related]
15. ACOG Committee Opinion No. 521: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Committee on Obstetric Practice Obstet Gynecol; 2012 Mar; 119(3):690-1. PubMed ID: 22353979 [TBL] [Abstract][Full Text] [Related]
16. Update on childhood and adolescent immunizations: selected review of US recommendations and literature: part 2. Lai J; Fay KE; Bocchini JA Curr Opin Pediatr; 2011 Aug; 23(4):470-81. PubMed ID: 21743328 [TBL] [Abstract][Full Text] [Related]
17. Update on immunizations in children and adolescents. Ackerman LK Am Fam Physician; 2008 Jun; 77(11):1561-8. PubMed ID: 18581836 [TBL] [Abstract][Full Text] [Related]
18. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(40):1302-6. PubMed ID: 20948508 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952 [TBL] [Abstract][Full Text] [Related]
20. Tdap vaccine: current indications for adolescent and adult patients in the United States. Kirchner JT J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S7-9. PubMed ID: 22086895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]